Suchergebnisse - "LI JING"

PubPharm (383)

1

The influence of a modified p53 C-terminal peptide by using a tumor-targeting sequence on cellular apoptosis and tumor treatment

enthalten in: Apoptosis : an international journal on programmed cell death | 2024

von Guo, X. | Zhang, Y. | Li, Q. | +4

2

"On/off"-switchable crosslinked PTX-nanoformulation with improved precise delivery for NSCLC brain metastases and restrained adverse reaction over nab-PTX

enthalten in: Biomaterials | 2024

von Li, S. | Meng, C. | Hao, Q. | +19

3

Evodiamine inhibits growth of vemurafenib drug-resistant melanoma via suppressing IRS4/PI3K/AKT signaling pathway

enthalten in: Journal of natural medicines | 2024

von Guo, X. | Huang, S. | Zhang, Y. | +6

4

Research Progress on hCNT3 Structure/Function and Nucleoside Anticancer Drugs

enthalten in: Current protein & peptide science | 2024

von Yue, X. | Zhang, X. | Zhang, D. | +9

5

Recent advances in pluripotent stem cell-derived cardiac organoids and heart-on-chip applications for studying anti-cancer drug-induced cardiotoxicity

enthalten in: Cell biology and toxicology | 2023

von Liu, S. | Fang, C. | Zhong, C. | +2

6

Exploring the clinical outcomes and safety profile of inetetamab treatment in metastatic breast cancer patients : A multicenter assessment of a Chinese-origin recombinant Anti-HER2 monoclonal antibody

enthalten in: Breast (Edinburgh, Scotland) | 2023

von Liu, B. | Xie, N. | Tian, C. | +16

7

In Situ Activation of the Receptor Aggregation for Cell Apoptosis by an AI-Au Intelligent Nanomachine via Tumor Extracellular Acidity

enthalten in: ACS applied materials & interfaces | 2023

von Zhang, Y. | Cheng, F. | Liang, R. | +6

8

Target proteins profiling of irreversible kinase inhibitor pelitinib and discovery of degradation of PRDX4 by label free chemoproteomics

enthalten in: Journal of pharmaceutical and biomedical analysis | 2023

von Li, J. | Zheng, M. | Xu, Y. | +2

9

Monomethylarsonous acid binds to Cys-104α and Cys-112β of hemoglobin in acute promyelocytic leukemia patients treated with arsenic trioxide

enthalten in: Toxicology letters | 2023

von Gao, C. | Lin, L. | Li, J. | +4

10

Population Pharmacokinetics and Exposure-Response Analysis for the Phase 3 COSMIC-311 Trial of Cabozantinib for Radioiodine-Refractory Differentiated Thyroid Cancer

enthalten in: Clinical pharmacokinetics | 2023

von Ly, N. | Li, J. | Faggioni, R. | +2

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[39]